EXEL
Exelixis, Inc. - Common Stock (EXEL)
$71
About Exelixis, Inc. - Common Stock (EXEL)
Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.
Details
Daily high
$73.69
Daily low
$68.46
Price at open
$73.03
52 Week High
$73.69
52 Week Low
$39.71
Market cap
17.8B
Dividend yield
-
Volume
3.0M
Avg. volume
2.7M
P/E ratio
21.77
Exelixis, Inc. - Common Stock News
Details
Daily high
$73.69
Daily low
$68.46
Price at open
$73.03
52 Week High
$73.69
52 Week Low
$39.71
Market cap
17.8B
Dividend yield
-
Volume
3.0M
Avg. volume
2.7M
P/E ratio
21.77